United States Financial Markets News
Sign up for free!
Get instant access to all of our market news and analysis with our free REST API.
Oops... There was a problem with your request.
- Country "dk" not found.
Search entities
Discover all 32,649 supported financial entities for United States financial markets here.
Latest news
Live response for past 24 hours
{
"meta": {
"found": 319,
"returned": 10,
"limit": 10,
"page": 1
},
"data": [
{
"uuid": "8ab1db95-6ca3-43fa-9906-296fb997eb04",
"title": "KKR Enhances Offer for Datagroup to 58 Euros Per Share | KKR Stock News",
"description": "KKR (KKR) has put forward an enhanced proposal to increase its potential acquisition bid for Datagroup, aiming to raise the offer to as much as 58 euros per sha",
"keywords": "GuruFocus, Article, News, GuruFocus News, KKR",
"snippet": "KKR (KKR, Financial) has put forward an enhanced proposal to increase its potential acquisition bid for Datagroup, aiming to raise the offer to as much as 58 eu...",
"url": "https://www.gurufocus.com/news/2900314/kkr-enhances-offer-for-datagroup-to-58-euros-per-share-kkr-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C00004VUS.png?20",
"language": "en",
"published_at": "2025-06-02T01:15:39.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "KKR",
"name": "KKR & Co. Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Financial Services",
"match_score": 60.434414,
"sentiment_score": 0.490886,
"highlights": [
{
"highlight": "<em>KKR</em> (<em>KKR</em>, Financial) h[+263 characters]",
"sentiment": 0.6908,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+301 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+361 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+258 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+326 characters]",
"sentiment": 0.5267,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>KKR</em> & <em>Co</[+300 characters]",
"sentiment": 0.9274,
"highlighted_in": "main_text"
},
{
"highlight": "<em>KKR</em> Enhances Offer for Datagroup to 58 Euros Per Share | <em>KKR</em> Stock News",
"sentiment": 0.296,
"highlighted_in": "title"
}
]
}
],
"similar": [
{
"uuid": "bef51ba0-f9ee-4b15-8ba6-057784a97a3f",
"title": "NetApp (NTAP) Target Price Raised by Citi Amid Positive Q4 Performance | NTAP Stock News",
"description": "Citi has increased its price target for NetApp (NTAP) from $105 to $110, maintaining a Neutral stance on the stock. The adjustment comes following the company's",
"keywords": "GuruFocus, Article, News, GuruFocus News, NTAP",
"snippet": "Citi has increased its price target for NetApp (NTAP, Financial) from $105 to $110, maintaining a Neutral stance on the stock. The adjustment comes following th...",
"url": "https://www.gurufocus.com/news/2900291/netapp-ntap-target-price-raised-by-citi-amid-positive-q4-performance-ntap-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C00000BS6.png?20",
"language": "en",
"published_at": "2025-06-02T00:45:50.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "0K6F.L",
"name": "NetApp, Inc.",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 52.30978,
"sentiment_score": 0.436311,
"highlights": [
{
"highlight": "Citi has increased its price target for [+245 characters]",
"sentiment": 0.7906,
"highlighted_in": "main_text"
},
{
"highlight": "Citi's analysis suggests that <em>NetApp[+113 characters]",
"sentiment": 0.8271,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+281 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+326 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+237 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+297 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>NetApp</em> <em>Inc[+171 characters]",
"sentiment": 0.8591,
"highlighted_in": "main_text"
},
{
"highlight": "<em>NetApp</em> <em>Inc</em> (NTAP) clos[+144 characters]",
"sentiment": -0.1027,
"highlighted_in": "main_text"
},
{
"highlight": "<em>NetApp</em> (NTAP) Target Price Raised by Citi Amid Positive Q4 Performance | NTAP Stock News",
"sentiment": 0.5574,
"highlighted_in": "title"
}
]
},
{
"symbol": "NTAP",
"name": "NetApp, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 52.30807,
"sentiment_score": 0.436311,
"highlights": [
{
"highlight": "Citi has increased its price target for [+245 characters]",
"sentiment": 0.7906,
"highlighted_in": "main_text"
},
{
"highlight": "Citi's analysis suggests that <em>NetApp[+113 characters]",
"sentiment": 0.8271,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+281 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+326 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+237 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+297 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>NetApp</em> <em>Inc[+171 characters]",
"sentiment": 0.8591,
"highlighted_in": "main_text"
},
{
"highlight": "<em>NetApp</em> <em>Inc</em> (NTAP) clos[+144 characters]",
"sentiment": -0.1027,
"highlighted_in": "main_text"
},
{
"highlight": "<em>NetApp</em> (NTAP) Target Price Raised by Citi Amid Positive Q4 Performance | NTAP Stock News",
"sentiment": 0.5574,
"highlighted_in": "title"
}
]
},
{
"symbol": "N1TA34.SA",
"name": "NetApp, Inc.",
"exchange": null,
"exchange_long": null,
"country": "br",
"type": "equity",
"industry": "Technology",
"match_score": 52.303528,
"sentiment_score": 0.436311,
"highlights": [
{
"highlight": "Citi has increased its price target for [+245 characters]",
"sentiment": 0.7906,
"highlighted_in": "main_text"
},
{
"highlight": "Citi's analysis suggests that <em>NetApp[+113 characters]",
"sentiment": 0.8271,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+281 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+326 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+237 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+297 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>NetApp</em> <em>Inc[+171 characters]",
"sentiment": 0.8591,
"highlighted_in": "main_text"
},
{
"highlight": "<em>NetApp</em> <em>Inc</em> (NTAP) clos[+144 characters]",
"sentiment": -0.1027,
"highlighted_in": "main_text"
},
{
"highlight": "<em>NetApp</em> (NTAP) Target Price Raised by Citi Amid Positive Q4 Performance | NTAP Stock News",
"sentiment": 0.5574,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "85b495d7-4b99-42dd-bf3c-f351053dd63d",
"title": "Avis Budget (CAR) Sees Significant Increase in Short Interest | CAR Stock News",
"description": "Avis Budget Group (CAR) has experienced a notable rise in short interest, climbing by 5.5 percentage points this week to reach 47.8%. This marks a significant i",
"keywords": "GuruFocus, Article, News, GuruFocus News, CAR",
"snippet": "Avis Budget Group (CAR, Financial) has experienced a notable rise in short interest, climbing by 5.5 percentage points this week to reach 47.8%. This marks a si...",
"url": "https://www.gurufocus.com/news/2900288/avis-budget-car-sees-significant-increase-in-short-interest-car-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C0000078N.png?20",
"language": "en",
"published_at": "2025-06-02T00:45:33.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "0HK4.L",
"name": "Avis Budget Group, Inc.",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 78.600266,
"sentiment_score": 0.472643,
"highlights": [
{
"highlight": "<em>Avis</em> <em>Budget</em> Group (CAR[+264 characters]",
"sentiment": 0.8481,
"highlighted_in": "main_text"
},
{
"highlight": "Throughout the four-day trading period e[+337 characters]",
"sentiment": 0.0258,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+291 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+265 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+299 characters]",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Avis</em> <em>Budge[+166 characters]",
"sentiment": 0.5719,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Avis</em> <em>Budget</em> (CAR) Sees Significant Increase in Short Interest | CAR Stock News",
"sentiment": 0.7269,
"highlighted_in": "title"
}
]
},
{
"symbol": "CAR",
"name": "Avis Budget Group, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Industrials",
"match_score": 78.599915,
"sentiment_score": 0.472643,
"highlights": [
{
"highlight": "<em>Avis</em> <em>Budget</em> Group (CAR[+264 characters]",
"sentiment": 0.8481,
"highlighted_in": "main_text"
},
{
"highlight": "Throughout the four-day trading period e[+337 characters]",
"sentiment": 0.0258,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+291 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+265 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+299 characters]",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Avis</em> <em>Budge[+166 characters]",
"sentiment": 0.5719,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Avis</em> <em>Budget</em> (CAR) Sees Significant Increase in Short Interest | CAR Stock News",
"sentiment": 0.7269,
"highlighted_in": "title"
}
]
},
{
"symbol": "CAR.BA",
"name": "Avis Budget Group, Inc.",
"exchange": null,
"exchange_long": null,
"country": "ar",
"type": "equity",
"industry": "Industrials",
"match_score": 78.60097,
"sentiment_score": 0.472643,
"highlights": [
{
"highlight": "<em>Avis</em> <em>Budget</em> Group (CAR[+264 characters]",
"sentiment": 0.8481,
"highlighted_in": "main_text"
},
{
"highlight": "Throughout the four-day trading period e[+337 characters]",
"sentiment": 0.0258,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+291 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+265 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+299 characters]",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Avis</em> <em>Budge[+166 characters]",
"sentiment": 0.5719,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Avis</em> <em>Budget</em> (CAR) Sees Significant Increase in Short Interest | CAR Stock News",
"sentiment": 0.7269,
"highlighted_in": "title"
}
]
}
]
}
]
},
{
"uuid": "0296aac2-c39f-4d30-b31b-3093aaf4d477",
"title": "Moderna (MRNA) Gains FDA Approval for Latest COVID-19 Vaccine | MRNA Stock News",
"description": "Moderna (MRNA) has secured approval from the U.S. Food and Drug Administration for its latest COVID-19 vaccine, mNEXSPIKE. This new vaccine is now cleared for u",
"keywords": "GuruFocus, Article, News, GuruFocus News, MRNA",
"snippet": "Moderna (MRNA, Financial) has secured approval from the U.S. Food and Drug Administration for its latest COVID-19 vaccine, mNEXSPIKE. This new vaccine is now cl...",
"url": "https://www.gurufocus.com/news/2900313/moderna-mrna-gains-fda-approval-for-latest-covid19-vaccine-mrna-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C0000BJB3.png?20",
"language": "en",
"published_at": "2025-06-02T01:15:33.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "MRNA",
"name": "Moderna, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 41.806564,
"sentiment_score": 0.453378,
"highlights": [
{
"highlight": "<em>Moderna</em> (MRNA, Financial) has s[+312 characters]",
"sentiment": 0.7351,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+280 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+328 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+239 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+302 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Moderna</em> <em>In[+295 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Moderna</em> <em>Inc</em> (MRNA) exp[+296 characters]",
"sentiment": 0.4215,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Moderna</em> <em>Inc</em> (MRNA) has[+157 characters]",
"sentiment": 0.4404,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Moderna</em> (MRNA) Gains FDA Approval for Latest COVID-19 Vaccine | MRNA Stock News",
"sentiment": 0.6705,
"highlighted_in": "title"
}
]
}
],
"similar": [
{
"uuid": "540d9111-510c-4aa6-be8a-3ff4429db2b3",
"title": "Arvinas (ARVN) Faces Downgrade Amid Clinical Trial Results | ARVN Stock News",
"description": "Arvinas (ARVN) has been downgraded by Leerink analyst Andrew Berens from an \"Outperform\" rating to \"Market Perform,\" with a price target reduction to $9 from $1",
"keywords": "GuruFocus, Article, News, GuruFocus News, ARVN",
"snippet": "Arvinas (ARVN, Financial) has been downgraded by Leerink analyst Andrew Berens from an \"Outperform\" rating to \"Market Perform,\" with a price target reduction to...",
"url": "https://www.gurufocus.com/news/2900284/arvinas-arvn-faces-downgrade-amid-clinical-trial-results-arvn-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C0000BIBF.png?20",
"language": "en",
"published_at": "2025-06-02T00:30:25.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "ARVN",
"name": "Arvinas, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 65.21175,
"sentiment_score": 0.165978,
"highlights": [
{
"highlight": "<em>Arvinas</em> (ARVN, Financial) has b[+142 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+278 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+334 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+237 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+325 characters]",
"sentiment": 0.296,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Arvinas</em> <em>In[+315 characters]",
"sentiment": 0.7906,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Arvinas</em> <em>Inc</em> (ARVN) rec[+305 characters]",
"sentiment": -0.4215,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Arvinas</em> <em>Inc</em> (ARVN) has[+162 characters]",
"sentiment": -0.2263,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Arvinas</em> (ARVN) Faces Downgrade Amid Clinical Trial Results | ARVN Stock News",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "b1f51aee-defd-4c42-bd2a-697bddc1ddda",
"title": "The Bancorp (TBBK) Faces Uncertain Real Estate Sale Outcome | TBBK Stock News",
"description": "The Bancorp (TBBK) recently shared details regarding a transaction involving a real estate bridge lending asset. The company's",
"keywords": "GuruFocus, Article, News, GuruFocus News, TBBK",
"snippet": "The Bancorp (TBBK, Financial) recently shared details regarding a transaction involving a real estate bridge lending asset. The company's \"Other Real Estate Own...",
"url": "https://www.gurufocus.com/news/2900267/the-bancorp-tbbk-faces-uncertain-real-estate-sale-outcome-tbbk-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C00000CMI.png?20",
"language": "en",
"published_at": "2025-06-01T23:00:20.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "TBBK",
"name": "The Bancorp, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Financial Services",
"match_score": 54.01596,
"sentiment_score": 0.313122,
"highlights": [
{
"highlight": "<em>The</em> <em>Bancorp</em> (TBBK, Fin[+260 characters]",
"sentiment": 0.5994,
"highlighted_in": "main_text"
},
{
"highlight": "Should this occur, <em>The</em> <em>Banc[+157 characters]",
"sentiment": 0.6597,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+291 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+272 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+252 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+260 characters]",
"sentiment": 0.8481,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>The</em> <em>Bancor[+248 characters]",
"sentiment": 0.8834,
"highlighted_in": "main_text"
},
{
"highlight": "<em>The</em> <em>Bancorp</em> <em>Inc</e[+166 characters]",
"sentiment": -0.3612,
"highlighted_in": "main_text"
},
{
"highlight": "<em>The</em> <em>Bancorp</em> (TBBK) Faces Uncertain Real Estate Sale Outcome | TBBK Stock News",
"sentiment": -0.296,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "46c58e91-0214-4848-ad12-59e3fcf9701c",
"title": "Li Auto (LI) Reports Strong Vehicle Deliveries in May 2025 | LI Stock News",
"description": "Li Auto (LI) reported that it delivered 40,856 vehicles in May 2025, marking a 16.7% increase compared to the same period last year. By the end of May, the comp",
"keywords": "GuruFocus, Article, News, GuruFocus News, LI",
"snippet": "Li Auto (LI, Financial) reported that it delivered 40,856 vehicles in May 2025, marking a 16.7% increase compared to the same period last year. By the end of Ma...",
"url": "https://www.gurufocus.com/news/2900251/li-auto-li-reports-strong-vehicle-deliveries-in-may-2025-li-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C0000BVHF.png?20",
"language": "en",
"published_at": "2025-06-01T21:45:44.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "LIAN.MX",
"name": "Li Auto Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "N/A",
"match_score": 70.52505,
"sentiment_score": 0.368944,
"highlights": [
{
"highlight": "<em>Li</em> <em>Auto</em> (LI, Financial[+303 characters]",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+286 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+348 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+245 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+309 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Li</em> <em>Auto</e[+242 characters]",
"sentiment": 0.7964,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Li</em> <em>Auto</em> <em>Inc</em> ([+282 characters]",
"sentiment": 0.743,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Li</em> <em>Auto</em> <em>Inc</em> ([+109 characters]",
"sentiment": -0.1027,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Li</em> <em>Auto</em> (LI) Reports Strong Vehicle Deliveries in May 2025 | LI Stock News",
"sentiment": 0.5106,
"highlighted_in": "title"
}
]
},
{
"symbol": "LI",
"name": "Li Auto Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 70.52484,
"sentiment_score": 0.368944,
"highlights": [
{
"highlight": "<em>Li</em> <em>Auto</em> (LI, Financial[+303 characters]",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+286 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+348 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+245 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+309 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Li</em> <em>Auto</e[+242 characters]",
"sentiment": 0.7964,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Li</em> <em>Auto</em> <em>Inc</em> ([+282 characters]",
"sentiment": 0.743,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Li</em> <em>Auto</em> <em>Inc</em> ([+109 characters]",
"sentiment": -0.1027,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Li</em> <em>Auto</em> (LI) Reports Strong Vehicle Deliveries in May 2025 | LI Stock News",
"sentiment": 0.5106,
"highlighted_in": "title"
}
]
}
]
}
]
},
{
"uuid": "f352b60c-3264-4fce-9f9d-7645fe75aa43",
"title": "American Airlines: Demand Fears Overstated, But Peers Are Stronger (NASDAQ:AAL)",
"description": "American Airlines faces near-term headwinds from economic uncertainty and tariffs, but these demand fears appear overstated. See why AAL stock is a Hold.",
"keywords": "",
"snippet": "I began my coverage of American Airlines (NASDAQ: AAL ) back in September 2023, initiating at a buy rating on continued post-pandemic growth, debt-reduction, an...",
"url": "https://seekingalpha.com/article/4791563-american-airlines-demand-fears-overstated-but-peers-are-stronger",
"image_url": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2183087062/image_2183087062.jpg?io=getty-c-w1536",
"language": "en",
"published_at": "2025-06-02T01:13:45.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "AAL",
"name": "American Airlines Group Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Industrials",
"match_score": 105.83812,
"sentiment_score": 0.10195,
"highlights": [
{
"highlight": "I began my coverage of <em>American</em>[+191 characters]",
"sentiment": 0.3818,
"highlighted_in": "main_text"
},
{
"highlight": "<em>American</em> <em>Airlines</em>: Demand Fears Overstated, But Peers Are Stronger (<em>NASDAQ:AAL</em>)",
"sentiment": -0.1779,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "72e244aa-6e4b-43e0-9cf9-d964ab6bd38c",
"title": "First Citizens Stock: Low Returns Offset Buyback Potential (NASDAQ:FCNCA)",
"description": "The SVB acquisition accelerated growth and expanded First Citizens' reach, but integration and regulatory costs loom. Read why I rate FCNCA stock a Hold.",
"keywords": "",
"snippet": "First Citizens Bancshares (NASDAQ: FCNCA ) ( OTCPK:FCNCB ) has been a respectable performer over the past year, gaining about 7%, as the bank has benefitted fro...",
"url": "https://seekingalpha.com/article/4791560-first-citizens-low-returns-offset-buyback-potential",
"image_url": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1594226545/image_1594226545.jpg?io=getty-c-w1536",
"language": "en",
"published_at": "2025-06-02T01:08:00.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "FCNCA",
"name": "First Citizens BancShares, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Financial Services",
"match_score": 102.03358,
"sentiment_score": 0.3089,
"highlights": [
{
"highlight": "<em>First</em> <em>Citizens</em> <em>Ban[+218 characters]",
"sentiment": 0.891,
"highlighted_in": "main_text"
},
{
"highlight": "First Citizens Stock: Low Returns Offset Buyback Potential (<em>NASDAQ:FCNCA</em>)",
"sentiment": -0.2732,
"highlighted_in": "title"
}
]
},
{
"symbol": "FCNCP",
"name": "First Citizens BancShares, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Financial Services",
"match_score": 25.378498,
"sentiment_score": 0.891,
"highlights": [
{
"highlight": "<em>First</em> <em>Citizens</em> <em>Ban[+200 characters]",
"sentiment": 0.891,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "c79b07dd-e235-43db-9eac-5302b59944c2",
"title": "Cenovus Energy Inc (CVE) Updates on Oil Sands Operations Amid Alberta Wildfires | CVE stock news",
"description": "Summary Cenovus Energy Inc (CVE) has issued an update regarding its Oil Sands operations in response to ongoing wildfire activity in northern Alberta. As of Jun",
"keywords": "GuruFocus, Article, News, GuruFocus News, CVE",
"snippet": "Summary\n\nCenovus Energy Inc (CVE, Financial) has issued an update regarding its Oil Sands operations in response to ongoing wildfire activity in northern Albert...",
"url": "https://www.gurufocus.com/news/2900307/cenovus-energy-inc-cve-updates-on-oil-sands-operations-amid-alberta-wildfires-cve-stock-news",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-06-02T01:01:48.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "CVE",
"name": "Cenovus Energy Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Energy",
"match_score": 110.12775,
"sentiment_score": -0.228267,
"highlights": [
{
"highlight": "Summary\n\n<em>Cenovus</em> <em>Energy</em[+149 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "FAQ\n\nQ: Are all <em>Cenovus</em> <em>Ene[+299 characters]",
"sentiment": -0.6848,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Cenovus</em> <em>Energy</em> <em>Inc</em> (CVE) Updates on Oil Sands Operations Amid Alberta Wildfires | CVE stock news",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "CVE-WT",
"name": "Cenovus Energy Inc",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "N/A",
"match_score": 110.12252,
"sentiment_score": -0.228267,
"highlights": [
{
"highlight": "Summary\n\n<em>Cenovus</em> <em>Energy</em[+149 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "FAQ\n\nQ: Are all <em>Cenovus</em> <em>Ene[+299 characters]",
"sentiment": -0.6848,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Cenovus</em> <em>Energy</em> <em>Inc</em> (CVE) Updates on Oil Sands Operations Amid Alberta Wildfires | CVE stock news",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": [
{
"uuid": "b9d76c66-28d1-4270-864b-d0a572ebe438",
"title": "Cenovus Energy (CVE) Prepares for Restart After Wildfire-Related Shutdown | CVE Stock News",
"description": "Cenovus Energy (CVE) has shared an update regarding its Oil Sands operations, which have been affected by ongoing wildfires in northern Alberta. The company ass",
"keywords": "GuruFocus, Article, News, GuruFocus News, CVE",
"snippet": "Cenovus Energy (CVE, Financial) has shared an update regarding its Oil Sands operations, which have been affected by ongoing wildfires in northern Alberta. The ...",
"url": "https://www.gurufocus.com/news/2900283/cenovus-energy-cve-prepares-for-restart-after-wildfirerelated-shutdown-cve-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C000049QY.png?20",
"language": "en",
"published_at": "2025-06-02T00:30:17.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "CVE",
"name": "Cenovus Energy Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Energy",
"match_score": 81.94061,
"sentiment_score": 0.393167,
"highlights": [
{
"highlight": "<em>Cenovus</em> <em>Energy</em> (CVE, F[+249 characters]",
"sentiment": 0.7845,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Cenovus</em> <em>Energy</em> aims to[+152 characters]",
"sentiment": 0.4404,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+293 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+276 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+252 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+266 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Cenovus</em> <em>En[+184 characters]",
"sentiment": 0.8807,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Cenovus</em> <em>Energy</em> <em>Inc[+158 characters]",
"sentiment": 0.8885,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Cenovus</em> <em>Energy</em> (CVE) Prepares for Restart After Wildfire-Related Shutdown | CVE Stock News",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "CVE-WT",
"name": "Cenovus Energy Inc",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "N/A",
"match_score": 81.93375,
"sentiment_score": 0.393167,
"highlights": [
{
"highlight": "<em>Cenovus</em> <em>Energy</em> (CVE, F[+249 characters]",
"sentiment": 0.7845,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Cenovus</em> <em>Energy</em> aims to[+152 characters]",
"sentiment": 0.4404,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+293 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+276 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+252 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+266 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Cenovus</em> <em>En[+184 characters]",
"sentiment": 0.8807,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Cenovus</em> <em>Energy</em> <em>Inc[+158 characters]",
"sentiment": 0.8885,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Cenovus</em> <em>Energy</em> (CVE) Prepares for Restart After Wildfire-Related Shutdown | CVE Stock News",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "fc8a569c-617d-4f8d-8ed6-2826c1aaceac",
"title": "Cenovus Energy provides operations update on impact of Alberta wildfires",
"description": "CALGARY, Alberta, June 01, 2025 (GLOBE NEWSWIRE) -- Cenovus Energy Inc. (TSX: CVE) (: CVE) is providing an update on its Oil Sands operations following ongoin",
"keywords": "GuruFocus, Article, News, Marketwired, CVE",
"snippet": "CALGARY, Alberta, June 01, 2025 (GLOBE NEWSWIRE) -- Cenovus Energy Inc. (TSX: CVE) (: CVE) is providing an update on its Oil Sands operations following ongoing ...",
"url": "https://www.gurufocus.com/news/2900272/cenovus-energy-provides-operations-update-on-impact-of-alberta-wildfires",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-06-02T00:00:02.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "CVE",
"name": "Cenovus Energy Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Energy",
"match_score": 83.174484,
"sentiment_score": 0.5602,
"highlights": [
{
"highlight": "CALGARY, Alberta, June 01, 2025 (GLOBE N[+289 characters]",
"sentiment": 0.93,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Cenovus</em> <em>Energy</em> <em>Inc[+254 characters]",
"sentiment": 0.7506,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Cenovus</em> <em>Energy</em> provides operations update on impact of Alberta wildfires",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "CVE-WT",
"name": "Cenovus Energy Inc",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "N/A",
"match_score": 83.16714,
"sentiment_score": 0.5602,
"highlights": [
{
"highlight": "CALGARY, Alberta, June 01, 2025 (GLOBE N[+289 characters]",
"sentiment": 0.93,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Cenovus</em> <em>Energy</em> <em>Inc[+254 characters]",
"sentiment": 0.7506,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Cenovus</em> <em>Energy</em> provides operations update on impact of Alberta wildfires",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "173e44fb-3dc5-4018-ae0d-ca4e1c9b2961",
"title": "Cenovus Energy provides operations update on impact of Alberta wildfires | CVE Stock News",
"description": "Cenovus Energy (CVE) has temporarily suspended operations at its Christina Lake oil sands facility due to wildfires in Alberta. This shutdown affects approx",
"keywords": "GuruFocus, Article, News, GuruFocus News, CVE",
"snippet": "Cenovus Energy (CVE, Financial) has temporarily suspended operations at its Christina Lake oil sands facility due to wildfires in Alberta.\n\nThis shutdown affect...",
"url": "https://www.gurufocus.com/news/2900269/cenovus-energy-provides-operations-update-on-impact-of-alberta-wildfires-cve-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C000049QY.png?20",
"language": "en",
"published_at": "2025-06-01T23:30:09.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "CVE",
"name": "Cenovus Energy Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Energy",
"match_score": 72.98018,
"sentiment_score": 0.09715,
"highlights": [
{
"highlight": "<em>Cenovus</em> <em>Energy</em> (CVE, F[+352 characters]",
"sentiment": -0.5574,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Cenovus</em> <em>Energy</em> is curr[+290 characters]",
"sentiment": 0.946,
"highlighted_in": "main_text"
},
{
"highlight": "Investors and stakeholders are advised t[+203 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Cenovus</em> <em>Energy</em> provides operations update on impact of Alberta wildfires | CVE Stock News",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "CVE-WT",
"name": "Cenovus Energy Inc",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "N/A",
"match_score": 72.976906,
"sentiment_score": 0.09715,
"highlights": [
{
"highlight": "<em>Cenovus</em> <em>Energy</em> (CVE, F[+352 characters]",
"sentiment": -0.5574,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Cenovus</em> <em>Energy</em> is curr[+290 characters]",
"sentiment": 0.946,
"highlighted_in": "main_text"
},
{
"highlight": "Investors and stakeholders are advised t[+203 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Cenovus</em> <em>Energy</em> provides operations update on impact of Alberta wildfires | CVE Stock News",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "CVE.TO",
"name": "Cenovus Energy Inc.",
"exchange": null,
"exchange_long": null,
"country": "ca",
"type": "equity",
"industry": "Energy",
"match_score": 72.9737,
"sentiment_score": 0.09715,
"highlights": [
{
"highlight": "<em>Cenovus</em> <em>Energy</em> (CVE, F[+352 characters]",
"sentiment": -0.5574,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Cenovus</em> <em>Energy</em> is curr[+290 characters]",
"sentiment": 0.946,
"highlighted_in": "main_text"
},
{
"highlight": "Investors and stakeholders are advised t[+203 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Cenovus</em> <em>Energy</em> provides operations update on impact of Alberta wildfires | CVE Stock News",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
}
]
},
{
"uuid": "d8dd67fe-ef27-4745-b5cd-9783b70c89c2",
"title": "Pacific Edge Ltd (PFGTF) (FY 2025) Earnings Call Highlights: Navigating Revenue Challenges and Strategic Milestones",
"description": "Operating Revenue: $21.8 million for FY25, down 8.6% from the prior year.Cash and Cash Equivalents: $22.6 million as of March 31, 2025.Average Sales Price (ASP",
"keywords": "GuruFocus, Article, News, GuruFocus News, PFGTF",
"snippet": "Release Date: May 29, 2025\n\nFor the complete transcript of the earnings call, please refer to the full earnings call transcript.\n\nPositive Points\n\nPacific Edge ...",
"url": "https://www.gurufocus.com/news/2900301/pacific-edge-ltd-pfgtf-fy-2025-earnings-call-highlights-navigating-revenue-challenges-and-strategic-milestones",
"image_url": "https://static.gurufocus.com/logos/0C00000O82.png?5",
"language": "en",
"published_at": "2025-06-02T01:00:29.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "PFGTF",
"name": "Pacific Edge Limited",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "N/A",
"match_score": 88.17945,
"sentiment_score": 0.612833,
"highlights": [
{
"highlight": "Positive Points\n\n<em>Pacific</em> <em>Ed[+295 characters]",
"sentiment": 0.8834,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pacific</em> <em>Edge</em> Ltd (<em>[+238 characters]",
"sentiment": 0.8779,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Pacific</em> <em>Edge</em> Ltd (<em>PFGTF</em>) (FY 2025) Earnings Call Highlights: Navigating Revenue Challenges and Strategic Milestones",
"sentiment": 0.0772,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "676ffd57-bc19-4d0a-a7b1-bcf4260cf560",
"title": "Sparta Capital Announces Filing of Interim Financial Statements",
"description": "Not for distribution to U.S. Newswire Services or for dissemination in the United States of America. Any failure to comply with this restriction may constitute",
"keywords": "GuruFocus, Article, News, ACCESSWIRE, TSXV:SAY",
"snippet": "Not for distribution to U.S. Newswire Services or for dissemination in the United States of America. Any failure to comply with this restriction may constitute ...",
"url": "https://www.gurufocus.com/news/2900292/sparta-capital-announces-filing-of-interim-financial-statements",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-06-02T01:00:02.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "SCAXF",
"name": "Sparta Capital Ltd.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Industrials",
"match_score": 38.66479,
"sentiment_score": 0.603,
"highlights": [
{
"highlight": "<em>Sparta</em> <em>Capital</em> <em>Ltd[+196 characters]",
"sentiment": 0.6486,
"highlighted_in": "main_text"
},
{
"highlight": "Neither TSX Venture Exchange nor its Reg[+271 characters]",
"sentiment": 0.5574,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "c3f2a126-0e21-43ed-993b-a1235d7a8d3c",
"title": "HUTCHMED Highlights SACHI Phase III Study Data Presented at the 2025 ASCO Annual Meeting",
"description": "”” The all-oral chemotherapy-free combination of savolitinib plus osimertinib demonstrated significant PFS benefit with a favorable safety profile in the SACHI",
"keywords": "GuruFocus, Article, News, Marketwired, HCM",
"snippet": "— The all-oral chemotherapy-free combination of savolitinib plus osimertinib demonstrated significant PFS benefit with a favorable safety profile in the SACHI...",
"url": "https://www.gurufocus.com/news/2900294/hutchmed-highlights-sachi-phase-iii-study-data-presented-at-the-2025-asco-annual-meeting",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-06-02T01:00:02.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "AZN",
"name": "AstraZeneca PLC",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 8.833407,
"sentiment_score": 0.743,
"highlights": [
{
"highlight": "Savolitinib is approved in China and is [+260 characters]",
"sentiment": 0.743,
"highlighted_in": "main_text"
}
]
}
],
"similar": [
{
"uuid": "b1cc8e17-6861-41fa-ba96-62d407a7978b",
"title": "Replimune (REPL) Highlights Promising RP1 Data at ASCO 2025 | REPL Stock News",
"description": "Replimune (REPL) Group unveiled new data for their RP1 treatment at the 2025 American Society of Clinical Oncology Annual Meeting in Chicago. The presentation c",
"keywords": "GuruFocus, Article, News, GuruFocus News, REPL",
"snippet": "Replimune (REPL, Financial) Group unveiled new data for their RP1 treatment at the 2025 American Society of Clinical Oncology Annual Meeting in Chicago. The pre...",
"url": "https://www.gurufocus.com/news/2900263/replimune-repl-highlights-promising-rp1-data-at-asco-2025-repl-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C0000BHIM.png?20",
"language": "en",
"published_at": "2025-06-01T22:00:59.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "REPL",
"name": "Replimune Group, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 67.00341,
"sentiment_score": 0.073367,
"highlights": [
{
"highlight": "<em>Replimune</em> (REPL, Financial) Gro[+305 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+295 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+271 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Replimune</em> <em>[+272 characters]",
"sentiment": 0.8834,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Replimune</em> is well-capitalized, [+133 characters]",
"sentiment": -0.5719,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Replimune</em> (REPL) Highlights Promising RP1 Data at ASCO 2025 | REPL Stock News",
"sentiment": 0.4019,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "e7190a9d-4bef-4bb1-a290-9b3bd0aba658",
"title": "AstraZeneca (AZN) Reports Positive Phase III Trial Results for IMFINZI | AZN Stock News",
"description": "AstraZeneca (AZN) announced encouraging findings from the MATTERHORN Phase III trial, highlighting that perioperative treatment with its drug IMFINZI, when comb",
"keywords": "GuruFocus, Article, News, GuruFocus News, AZN",
"snippet": "AstraZeneca (AZN, Financial) announced encouraging findings from the MATTERHORN Phase III trial, highlighting that perioperative treatment with its drug IMFINZI...",
"url": "https://www.gurufocus.com/news/2900246/astrazeneca-azn-reports-positive-phase-iii-trial-results-for-imfinzi-azn-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C00000AGP.png?20",
"language": "en",
"published_at": "2025-06-01T21:30:33.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "ZEG.DE",
"name": "AstraZeneca PLC",
"exchange": null,
"exchange_long": null,
"country": "de",
"type": "equity",
"industry": "Healthcare",
"match_score": 51.043594,
"sentiment_score": 0.512388,
"highlights": [
{
"highlight": "<em>AstraZeneca</em> (AZN, Financial) an[+267 characters]",
"sentiment": 0.34,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+283 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+253 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+239 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+228 characters]",
"sentiment": 0.8934,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>AstraZeneca</em> <e[+267 characters]",
"sentiment": 0.9565,
"highlighted_in": "main_text"
},
{
"highlight": "<em>AstraZeneca</em> <em>PLC</em> (AZN) [+222 characters]",
"sentiment": 0.8074,
"highlighted_in": "main_text"
},
{
"highlight": "<em>AstraZeneca</em> (AZN) Reports Positive Phase III Trial Results for IMFINZI | AZN Stock News",
"sentiment": 0.5574,
"highlighted_in": "title"
}
]
},
{
"symbol": "AZNCF",
"name": "AstraZeneca PLC",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 51.043594,
"sentiment_score": 0.512388,
"highlights": [
{
"highlight": "<em>AstraZeneca</em> (AZN, Financial) an[+267 characters]",
"sentiment": 0.34,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+283 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+253 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+239 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+228 characters]",
"sentiment": 0.8934,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>AstraZeneca</em> <e[+267 characters]",
"sentiment": 0.9565,
"highlighted_in": "main_text"
},
{
"highlight": "<em>AstraZeneca</em> <em>PLC</em> (AZN) [+222 characters]",
"sentiment": 0.8074,
"highlighted_in": "main_text"
},
{
"highlight": "<em>AstraZeneca</em> (AZN) Reports Positive Phase III Trial Results for IMFINZI | AZN Stock News",
"sentiment": 0.5574,
"highlighted_in": "title"
}
]
},
{
"symbol": "AZNN.MX",
"name": "AstraZeneca PLC",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Healthcare",
"match_score": 51.041195,
"sentiment_score": 0.512388,
"highlights": [
{
"highlight": "<em>AstraZeneca</em> (AZN, Financial) an[+267 characters]",
"sentiment": 0.34,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+283 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+253 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+239 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+228 characters]",
"sentiment": 0.8934,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>AstraZeneca</em> <e[+267 characters]",
"sentiment": 0.9565,
"highlighted_in": "main_text"
},
{
"highlight": "<em>AstraZeneca</em> <em>PLC</em> (AZN) [+222 characters]",
"sentiment": 0.8074,
"highlighted_in": "main_text"
},
{
"highlight": "<em>AstraZeneca</em> (AZN) Reports Positive Phase III Trial Results for IMFINZI | AZN Stock News",
"sentiment": 0.5574,
"highlighted_in": "title"
}
]
},
{
"symbol": "AZN.L",
"name": "AstraZeneca PLC",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "Healthcare",
"match_score": 51.039776,
"sentiment_score": 0.512388,
"highlights": [
{
"highlight": "<em>AstraZeneca</em> (AZN, Financial) an[+267 characters]",
"sentiment": 0.34,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+283 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+253 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+239 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+228 characters]",
"sentiment": 0.8934,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>AstraZeneca</em> <e[+267 characters]",
"sentiment": 0.9565,
"highlighted_in": "main_text"
},
{
"highlight": "<em>AstraZeneca</em> <em>PLC</em> (AZN) [+222 characters]",
"sentiment": 0.8074,
"highlighted_in": "main_text"
},
{
"highlight": "<em>AstraZeneca</em> (AZN) Reports Positive Phase III Trial Results for IMFINZI | AZN Stock News",
"sentiment": 0.5574,
"highlighted_in": "title"
}
]
},
{
"symbol": "AZN",
"name": "AstraZeneca PLC",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 51.035656,
"sentiment_score": 0.512388,
"highlights": [
{
"highlight": "<em>AstraZeneca</em> (AZN, Financial) an[+267 characters]",
"sentiment": 0.34,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+283 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+253 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+239 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+228 characters]",
"sentiment": 0.8934,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>AstraZeneca</em> <e[+267 characters]",
"sentiment": 0.9565,
"highlighted_in": "main_text"
},
{
"highlight": "<em>AstraZeneca</em> <em>PLC</em> (AZN) [+222 characters]",
"sentiment": 0.8074,
"highlighted_in": "main_text"
},
{
"highlight": "<em>AstraZeneca</em> (AZN) Reports Positive Phase III Trial Results for IMFINZI | AZN Stock News",
"sentiment": 0.5574,
"highlighted_in": "title"
}
]
},
{
"symbol": "0A4J.L",
"name": "AstraZeneca PLC",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 51.03566,
"sentiment_score": 0.512388,
"highlights": [
{
"highlight": "<em>AstraZeneca</em> (AZN, Financial) an[+267 characters]",
"sentiment": 0.34,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+283 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+253 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+239 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+228 characters]",
"sentiment": 0.8934,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>AstraZeneca</em> <e[+267 characters]",
"sentiment": 0.9565,
"highlighted_in": "main_text"
},
{
"highlight": "<em>AstraZeneca</em> <em>PLC</em> (AZN) [+222 characters]",
"sentiment": 0.8074,
"highlighted_in": "main_text"
},
{
"highlight": "<em>AstraZeneca</em> (AZN) Reports Positive Phase III Trial Results for IMFINZI | AZN Stock News",
"sentiment": 0.5574,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "9d493cd3-cf5e-4593-8f68-88eb1fbc0a55",
"title": "Gilead (GILD) Presents Yescarta Study Results at ASCO 2025 | GILD Stock News",
"description": "Kite, a subsidiary of Gilead Sciences (GILD), has shared insights from a study assessing the real-world application of Yescarta for patients with relapsed or re",
"keywords": "GuruFocus, Article, News, GuruFocus News, GILD",
"snippet": "Kite, a subsidiary of Gilead Sciences (GILD, Financial), has shared insights from a study assessing the real-world application of Yescarta for patients with rel...",
"url": "https://www.gurufocus.com/news/2900245/gilead-gild-presents-yescarta-study-results-at-asco-2025-gild-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C000007VR.png?20",
"language": "en",
"published_at": "2025-06-01T21:30:24.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "GIS.DE",
"name": "Gilead Sciences, Inc.",
"exchange": null,
"exchange_long": null,
"country": "de",
"type": "equity",
"industry": "Healthcare",
"match_score": 59.202827,
"sentiment_score": 0.16494,
"highlights": [
{
"highlight": "Kite, a subsidiary of <em>Gilead</em> <e[+312 characters]",
"sentiment": 0.34,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+298 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+281 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+257 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+66 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "GILD.MX",
"name": "Gilead Sciences, Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Healthcare",
"match_score": 59.20261,
"sentiment_score": 0.16494,
"highlights": [
{
"highlight": "Kite, a subsidiary of <em>Gilead</em> <e[+312 characters]",
"sentiment": 0.34,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+298 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+281 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+257 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+66 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "GILD",
"name": "Gilead Sciences, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 59.200733,
"sentiment_score": 0.16494,
"highlights": [
{
"highlight": "Kite, a subsidiary of <em>Gilead</em> <e[+312 characters]",
"sentiment": 0.34,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+298 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+281 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+257 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+66 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "GILDD.BA",
"name": "GILEAD SCIENCES",
"exchange": null,
"exchange_long": null,
"country": "ar",
"type": "equity",
"industry": "N/A",
"match_score": 54.99148,
"sentiment_score": 0.16494,
"highlights": [
{
"highlight": "Kite, a subsidiary of <em>Gilead</em> <e[+312 characters]",
"sentiment": 0.34,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+289 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+272 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+248 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+57 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
}
]
}
]
},
{
"uuid": "c79cadf6-d525-443b-83bb-958f8a423950",
"title": "SGDM: Gold Miners +50% In 2025, And More Upside Is Likely (NYSEARCA:SGDM)",
"description": "Gold mining stocks and SGDM ETF have outperformed gold and the S&P 500, with SGDM up 55% year-to-date. Read why I issue a Buy rating for SGDM.",
"keywords": "",
"snippet": "Gold continues to shine in 2025. Year to date, the precious metal is up more than 25%. Better yet, shares of gold mining companies have scored massive gains—t...",
"url": "https://seekingalpha.com/article/4791559-sgdm-gold-miners-plus-50-percent-in-2025-and-more-upside-is-likely",
"image_url": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1363128262/image_1363128262.jpg?io=getty-c-w1536",
"language": "en",
"published_at": "2025-06-02T00:49:34.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "SGDM",
"name": "Sprott Gold Miners ETF",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "etf",
"industry": "N/A",
"match_score": 141.86414,
"sentiment_score": 0.4063,
"highlights": [
{
"highlight": "Better yet, shares of gold mining compan[+376 characters]",
"sentiment": 0.8126,
"highlighted_in": "main_text"
},
{
"highlight": "SGDM: Gold Miners +50% In 2025, And More Upside Is Likely (<em>NYSEARCA:SGDM</em>)",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "e0ce1fd1-d174-480b-bd67-adeec0708994",
"title": "Novartis (NVS) Highlights Positive Results from Kisqali Study in Treating Early Breast Cancer | NVS Stock News",
"description": "Novartis (NVS) has unveiled new findings from a subgroup analysis of its Phase III NATALEE trial, which assessed the effectiveness and safety of Kisqali combine",
"keywords": "GuruFocus, Article, News, GuruFocus News, NVS",
"snippet": "Novartis (NVS, Financial) has unveiled new findings from a subgroup analysis of its Phase III NATALEE trial, which assessed the effectiveness and safety of Kisq...",
"url": "https://www.gurufocus.com/news/2900289/novartis-nvs-highlights-positive-results-from-kisqali-study-in-treating-early-breast-cancer-nvs-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C00000BWJ.png?20",
"language": "en",
"published_at": "2025-06-02T00:45:41.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "NVS",
"name": "Novartis AG",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 50.559235,
"sentiment_score": 0.398775,
"highlights": [
{
"highlight": "<em>Novartis</em> (NVS, Financial) has u[+165 characters]",
"sentiment": 0.4215,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+282 characters]",
"sentiment": -0.4767,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+326 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+237 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+309 characters]",
"sentiment": 0.765,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Novartis</em> <em>A[+207 characters]",
"sentiment": 0.8957,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Novartis</em> <em>AG</em> (NVS) upgr[+275 characters]",
"sentiment": 0.4588,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Novartis</em> (NVS) Highlights Positive Results from Kisqali Study in Treating Early Breast Cancer | NVS Stock News",
"sentiment": -0.2023,
"highlighted_in": "title"
}
]
},
{
"symbol": "NVSEF",
"name": "Novartis AG",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 50.557747,
"sentiment_score": 0.398775,
"highlights": [
{
"highlight": "<em>Novartis</em> (NVS, Financial) has u[+165 characters]",
"sentiment": 0.4215,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+282 characters]",
"sentiment": -0.4767,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+326 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+237 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+309 characters]",
"sentiment": 0.765,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Novartis</em> <em>A[+207 characters]",
"sentiment": 0.8957,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Novartis</em> <em>AG</em> (NVS) upgr[+275 characters]",
"sentiment": 0.4588,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Novartis</em> (NVS) Highlights Positive Results from Kisqali Study in Treating Early Breast Cancer | NVS Stock News",
"sentiment": -0.2023,
"highlighted_in": "title"
}
]
}
],
"similar": [
{
"uuid": "a5e2b474-d7c3-4885-852a-7d16b44a65ea",
"title": "Seer (SEER) Launches Groundbreaking Cancer Biomarker Study | SEER Stock News",
"description": "Seer (SEER) has initiated an ambitious study focused on discovering new blood-based biomarkers for cancer diagnostics in young adults, specifically targeting th",
"keywords": "GuruFocus, Article, News, GuruFocus News, SEER",
"snippet": "Seer (SEER, Financial) has initiated an ambitious study focused on discovering new blood-based biomarkers for cancer diagnostics in young adults, specifically t...",
"url": "https://www.gurufocus.com/news/2900262/seer-seer-launches-groundbreaking-cancer-biomarker-study-seer-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C0000BZUB.png?20",
"language": "en",
"published_at": "2025-06-01T22:00:48.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "SEER",
"name": "Seer, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 78.46973,
"sentiment_score": 0.325767,
"highlights": [
{
"highlight": "<em>Seer</em> (<em>SEER</em>, Financial)[+174 characters]",
"sentiment": 0.0772,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+280 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+339 characters]",
"sentiment": 0.5106,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+241 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+346 characters]",
"sentiment": 0.743,
"highlighted_in": "main_text"
},
{
"highlight": "Positive Points\n\n<em>Seer</em> <em>Inc</[+290 characters]",
"sentiment": 0.8658,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Seer</em> <em>Inc</em> (<em>SEER</em[+317 characters]",
"sentiment": 0.9022,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Seer</em> <em>Inc</em> (<em>SEER</em[+184 characters]",
"sentiment": -0.0516,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Seer</em> (<em>SEER</em>) Launches Groundbreaking Cancer Biomarker Study | <em>SEER</em> Stock News",
"sentiment": -0.6597,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "c34230ff-5cef-4146-b934-341bc96874f2",
"title": "Regeneron (REGN) Highlights Promising Phase 3 Trial Results for Libtayo | REGN Stock News",
"description": "Regeneron Pharmaceuticals (REGN) has unveiled comprehensive findings from the Phase 3 C-POST trial concerning Libtayo, a PD-1 inhibitor, for treating patients w",
"keywords": "GuruFocus, Article, News, GuruFocus News, REGN",
"snippet": "Regeneron Pharmaceuticals (REGN, Financial) has unveiled comprehensive findings from the Phase 3 C-POST trial concerning Libtayo, a PD-1 inhibitor, for treating...",
"url": "https://www.gurufocus.com/news/2900250/regeneron-regn-highlights-promising-phase-3-trial-results-for-libtayo-regn-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C000008R4.png?20",
"language": "en",
"published_at": "2025-06-01T21:45:36.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "REGN.MX",
"name": "Regeneron Pharmaceuticals, Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Healthcare",
"match_score": 57.823956,
"sentiment_score": 0.124683,
"highlights": [
{
"highlight": "<em>Regeneron</em> <em>Pharmaceuticals</[+217 characters]",
"sentiment": 0.1779,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+312 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+301 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+266 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+320 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Regeneron</em> <em>Pharmaceuticals</[+332 characters]",
"sentiment": 0.0258,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "REGN",
"name": "Regeneron Pharmaceuticals, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 57.822903,
"sentiment_score": 0.124683,
"highlights": [
{
"highlight": "<em>Regeneron</em> <em>Pharmaceuticals</[+217 characters]",
"sentiment": 0.1779,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+312 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+301 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+266 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+320 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Regeneron</em> <em>Pharmaceuticals</[+332 characters]",
"sentiment": 0.0258,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "0R2M.L",
"name": "Regeneron Pharmaceuticals, Inc.",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 57.82254,
"sentiment_score": 0.124683,
"highlights": [
{
"highlight": "<em>Regeneron</em> <em>Pharmaceuticals</[+217 characters]",
"sentiment": 0.1779,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+312 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+301 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+266 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+320 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Regeneron</em> <em>Pharmaceuticals</[+332 characters]",
"sentiment": 0.0258,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "REGN34.SA",
"name": "Regeneron Pharmaceuticals, Inc.",
"exchange": null,
"exchange_long": null,
"country": "br",
"type": "equity",
"industry": "Healthcare",
"match_score": 57.822662,
"sentiment_score": 0.124683,
"highlights": [
{
"highlight": "<em>Regeneron</em> <em>Pharmaceuticals</[+217 characters]",
"sentiment": 0.1779,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+312 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+301 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+266 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+320 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Regeneron</em> <em>Pharmaceuticals</[+332 characters]",
"sentiment": 0.0258,
"highlighted_in": "main_text"
}
]
}
]
},
{
"uuid": "6e668e4f-046c-4023-8bdb-c4e1b03769a0",
"title": "Merck's (MRK) Keytruda-Trodelvy Combo Shows Significant Benefits in Breast Cancer Treatment | MRK Stock News",
"description": "Merck (MRK), internationally referred to as MSD, has unveiled promising findings from a study involving its cancer drug KEYTRUDA in combination with Trodelvy. T",
"keywords": "GuruFocus, Article, News, GuruFocus News, MRK",
"snippet": "Merck (MRK, Financial), internationally referred to as MSD, has unveiled promising findings from a study involving its cancer drug KEYTRUDA in combination with ...",
"url": "https://www.gurufocus.com/news/2900240/mercks-mrk-keytrudatrodelvy-combo-shows-significant-benefits-in-breast-cancer-treatment-mrk-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C000008C5.png?20",
"language": "en",
"published_at": "2025-06-01T21:15:49.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "MRKD.BA",
"name": "MERCK & CO INC",
"exchange": null,
"exchange_long": null,
"country": "ar",
"type": "equity",
"industry": "N/A",
"match_score": 38.787174,
"sentiment_score": 0.0285,
"highlights": [
{
"highlight": "<em>Merck</em> (MRK, Financial), interna[+138 characters]",
"sentiment": -0.4019,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+292 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+260 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+248 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+60 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "MRK.SN",
"name": "Merck & Co., Inc.",
"exchange": null,
"exchange_long": null,
"country": "cl",
"type": "equity",
"industry": "Healthcare",
"match_score": 38.7865,
"sentiment_score": 0.0285,
"highlights": [
{
"highlight": "<em>Merck</em> (MRK, Financial), interna[+138 characters]",
"sentiment": -0.4019,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+292 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+260 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+248 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+60 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "MRK",
"name": "Merck & Co., Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 38.78658,
"sentiment_score": 0.0285,
"highlights": [
{
"highlight": "<em>Merck</em> (MRK, Financial), interna[+138 characters]",
"sentiment": -0.4019,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+292 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+260 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+248 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+60 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "6MK.DE",
"name": "Merck & Co., Inc.",
"exchange": null,
"exchange_long": null,
"country": "de",
"type": "equity",
"industry": "Healthcare",
"match_score": 38.78656,
"sentiment_score": 0.0285,
"highlights": [
{
"highlight": "<em>Merck</em> (MRK, Financial), interna[+138 characters]",
"sentiment": -0.4019,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+292 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+260 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+248 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+60 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "MRK.PA",
"name": "Merck & Co., Inc.",
"exchange": null,
"exchange_long": null,
"country": "fr",
"type": "equity",
"industry": "Healthcare",
"match_score": 38.786766,
"sentiment_score": 0.0285,
"highlights": [
{
"highlight": "<em>Merck</em> (MRK, Financial), interna[+138 characters]",
"sentiment": -0.4019,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+292 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+260 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+248 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+60 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "MRK.MX",
"name": "Merck & Co., Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Healthcare",
"match_score": 38.78688,
"sentiment_score": 0.0285,
"highlights": [
{
"highlight": "<em>Merck</em> (MRK, Financial), interna[+138 characters]",
"sentiment": -0.4019,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+292 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+260 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+248 characters]",
"sentiment": 0.8176,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+60 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
}
]
},
{
"uuid": "229decea-ea71-477f-b2b4-7ef6bbbf5dd8",
"title": "GILD: Gilead's Trodelvy Shows Significant Benefit in Breast Cancer Study | GILD Stock News",
"description": "Gilead Sciences (GILD) has announced promising results from a pivotal study involving Trodelvy and Keytruda in treating PD-L1+ metastatic triple-negative breast",
"keywords": "GuruFocus, Article, News, GuruFocus News, GILD",
"snippet": "Gilead Sciences (GILD, Financial) has announced promising results from a pivotal study involving Trodelvy and Keytruda in treating PD-L1+ metastatic triple-nega...",
"url": "https://www.gurufocus.com/news/2900233/gild-gileads-trodelvy-shows-significant-benefit-in-breast-cancer-study-gild-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C000007VR.png?20",
"language": "en",
"published_at": "2025-06-01T21:00:37.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "GILDD.BA",
"name": "GILEAD SCIENCES",
"exchange": null,
"exchange_long": null,
"country": "ar",
"type": "equity",
"industry": "N/A",
"match_score": 54.513367,
"sentiment_score": -0.06848,
"highlights": [
{
"highlight": "<em>Gilead</em> <em>Sciences</em> (GILD,[+327 characters]",
"sentiment": -0.8271,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+289 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+272 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+248 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+57 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "GILD",
"name": "Gilead Sciences, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 58.57052,
"sentiment_score": -0.06848,
"highlights": [
{
"highlight": "<em>Gilead</em> <em>Sciences</em> (GILD,[+327 characters]",
"sentiment": -0.8271,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+298 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+281 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+257 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+66 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "GIS.DE",
"name": "Gilead Sciences, Inc.",
"exchange": null,
"exchange_long": null,
"country": "de",
"type": "equity",
"industry": "Healthcare",
"match_score": 58.567093,
"sentiment_score": -0.06848,
"highlights": [
{
"highlight": "<em>Gilead</em> <em>Sciences</em> (GILD,[+327 characters]",
"sentiment": -0.8271,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+298 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+281 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+257 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+66 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "GILD.MX",
"name": "Gilead Sciences, Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Healthcare",
"match_score": 58.56688,
"sentiment_score": -0.06848,
"highlights": [
{
"highlight": "<em>Gilead</em> <em>Sciences</em> (GILD,[+327 characters]",
"sentiment": -0.8271,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nBased on [+298 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed estimate data can be found[+281 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Based on GuruFocus estimates, the estima[+257 characters]",
"sentiment": 0.7579,
"highlighted_in": "main_text"
},
{
"highlight": "More detailed data can be found on the <[+66 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
}
]
}
]
}
]
}
Sentiment
Live response for past 24 hours
{
"meta": {
"returned": 1,
"limit": 10
},
"data": [
{
"key": "us",
"total_documents": 575,
"sentiment_avg": 0.22406588793993076
}
]
}
Other details
Entity count
- 32,649